pyrazole has been researched along with Diabetes Mellitus, Type 2 in 1 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiong, Y | 1 |
| Guo, J | 1 |
| Candelore, MR | 1 |
| Liang, R | 1 |
| Miller, C | 1 |
| Dallas-Yang, Q | 1 |
| Jiang, G | 1 |
| McCann, PE | 1 |
| Qureshi, SA | 1 |
| Tong, X | 1 |
| Xu, SS | 1 |
| Shang, J | 1 |
| Vincent, SH | 1 |
| Tota, LM | 1 |
| Wright, MJ | 1 |
| Yang, X | 1 |
| Zhang, BB | 1 |
| Tata, JR | 1 |
| Parmee, ER | 1 |
1 other study available for pyrazole and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the treatment of type II diabetes.
Topics: Animals; Area Under Curve; beta-Alanine; Blood Glucose; CHO Cells; Cricetinae; Cricetulus; Diabetes | 2012 |